Increased levels of homocysteine in patients with ulcerative colitis

Table 1 Demographic features of UC and control groups

	Patients with UC (n = 55)	Healthy controls (n = 45)	P
Mean age (yr ± SD)	47.4 ± 13.80	46.4 ± 13.89	0.484
Gender (male/female)	38/17	31/14	0.983
Smoking status (%)	17 (30.9)	15 (33.3)	0.796
Localization (%)
Rectum/sigmoid	34 (61.8)
Left colitis	12 (21.8)
Pancolitis	9 (26.4)
Activity of UC (%)
Active	28 (50.9)
Inactive	27 (49.1)
Medical treatment (%)
5-ASA	41 (74.5)
Steroids	3 (5.5)
AZA	11 (20.0)

UC: Ulcerative colitis; ASA: Aminosalicylic-acid; AZA: Azathioprine.